Toxicology Drug Screening Market Forecasted to Reach USD $33.48 Billion by 2030 at 9.2% CAGR

The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

How Does the Market Size of the Toxicology Drug Screening Market in 2030 Compare With That of 2026?
The toxicology drug screening market size has grown strongly in recent years. It will grow from $21.44 billion in 2025 to $23.5 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to reliance on manual toxicology testing methods, limited laboratory automation, growing prevalence of substance abuse monitoring, increasing regulatory oversight, adoption of conventional bioanalytical instrumentation.

The toxicology drug screening market size is expected to see strong growth in the next few years. It will grow to $33.48 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to development of ai-driven predictive toxicology tools, integration of genomics and transcriptomics in screening, growth of contract research organizations (cros), rising demand for real-time drug monitoring systems, implementation of cloud-based and secure data management platforms. Major trends in the forecast period include growing adoption of high-throughput screening technologies, integration of lims and laboratory information systems, rising use of predictive and ai-powered toxicology platforms, expansion of workplace drug screening programs, enhanced focus on data security and compliance standards.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report

What Are the Most Significant Drivers Affecting the Toxicology Drug Screening Market Expansion?
The rising prevalence of drug abuse is expected to propel the growth of the toxicology drug screening market going forward. Drug abuse is the harmful or excessive use of drugs for non-medical purposes that negatively impacts a person’s health and life. The prevalence of drug abuse is rising due to increased stress and mental health challenges, which lead many individuals to misuse substances as a way to cope. Toxicology drug screening is useful for drug abuse because it helps detect the presence of drugs or their metabolites in a person’s body, enabling early identification, diagnosis, and monitoring of substance misuse or overdose. For instance, in August 2024, according to the National Records of Scotland (NRS), a Scotland-based government department, Scotland recorded 1,172 drug misuse deaths in 2023, marking a 12% rise (121 additional deaths) compared to 2022. Therefore, the rising prevalence of drug abuse is driving the toxicology drug screening market.

How Is the Toxicology Drug Screening Market Arranged by Segment Classification?
The toxicology drug screening market covered in this report is segmented –

1) By Type: Screening Assays, Analytical Confirmatory Tests, Sample Collection Devices, Laboratory Consumables, Rapid Point-of-Care Tests, Laboratory Software And Reporting Systems
2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity
3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening
4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications
5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities

Subsegments:
1) By Screening Assays: Immunoassay Drug Screening Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Lateral Flow Rapid Screening Assays, Fluorescence Polarization Immunoassays
2) By Analytical Confirmatory Tests: Gas Chromatography–Mass Spectrometry (GC-MS), Liquid Chromatography–Mass Spectrometry (LC-MS/MS), High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis Toxicology Tests
3) By Sample Collection Devices: Urine Drug Collection Cups, Saliva (Oral Fluid) Collection Devices, Blood Collection Tubes, Hair Drug Collection Kits
4) By Laboratory Consumables: Calibrators And Controls, Reagents And Buffers, Extraction Cartridges And Columns, Sample Preparation Kits
5) By Rapid Point-of-Care Tests: Multi-Panel Urine Dip Cards, Saliva Drug Screening Cassettes, Breath Alcohol And Drug Screening Devices, Single-Drug Detection Test Strips
6) By Laboratory Software And Reporting Systems: Laboratory Information Management Systems (LIMS), Toxicology Reporting And Result Interpretation Software, Chain-of-Custody Tracking Software, Compliance And Audit Documentation Systems

Which Emerging Trends Are Driving the Toxicology Drug Screening Market?
Major companies operating in the toxicology drug screening market are focusing on introducing innovative solutions, such as the 3D liver microphysiological system, which allows for culturing highly biomimetic human liver microtissues with organized cell arrangements and active metabolic function. 3D liver microphysiological system (MPS) is an advanced in vitro platform designed to replicate the physiological microenvironment of the human liver more accurately than traditional cell culture methods and typically involves culturing multiple types of human liver cells. For instance, in February 2025, CN Bio Innovations Ltd., a U.K.-based life sciences company specializing in the development of organ-on-a-chip (OOC) technologies, launched the PhysioMimix DILI assay kit, an all-in-one laboratory kit developed for in vitro profiling of human drug-induced liver injury and a highly characterized 3D liver microphysiological system (MPS) that recreates metabolically active, highly functional human liver tissue and Kupffer cells. Additionally, it also offers effortless adoption of organ-on-a-chip technology with a plug-and-play format, simplifying implementation and reducing time to adoption.

Who Are the Most Influential Players in the Toxicology Drug Screening Market?
Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.

Get the full toxicology drug screening market report here:
https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report

Which regions are expected to dominate the Toxicology Drug Screening Market during the forecast period?
North America was the largest region in the toxicology drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn